封面
市場調查報告書
商品編碼
2176699

一氧化氮吸入裝置市場:全球市場預測,2026-2032年

Inhaled Nitric Oxide Delivery Device Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,吸入式一氧化氮給藥裝置市場將成長至 3.9822 億美元,複合年成長率為 6.04%。

主要市場統計數據
基準年 2025 2.6411億美元
預計年份:2026年 2.8153億美元
預測年份 2032 3.9822億美元
複合年成長率 (%) 6.04%

吸入式一氧化氮輸送裝置:概述

吸入式一氧化氮輸送裝置可支援在臨床環境中進行可控的一氧化氮給藥,尤其適用於需要選擇性肺血管擴張和氧合管理的場合。其應用與新生兒科、兒童、心臟科、呼吸科和重症監護等臨床流程密切相關。該裝置的價值在於其精確的劑量控制、可靠的氣體混合、持續的監測、警報功能以及與人工呼吸器和其他呼吸設備的可靠整合。

與臨床環境的融合以及安全性正在重新定義設備要求。

目前的趨勢是從獨立的供氣裝置轉向整合系統,這些系統集精準給藥、呼吸管路相容性、監測、記錄和工作流程支援於一體。醫院越來越重視不間斷運作、易於安裝、高效維護以及防止過度暴露和不當給藥的安全措施。監管要求、感染防治要求、臨床醫生培訓以及病患轉運過程中可靠性能的需求也會影響採購和部署決策。

人工智慧增強了監控、工作流程和預測支援。

人工智慧 (AI) 可以透過識別劑量、流速、濃度或迴路運行中的偏差,以及及早發現維護需求,來改善吸入一氧化氮的給藥。此外,機器學習工具可用於將設備測量值與呼吸和血流動力學數據關聯起來,從而減少人工驗證並改善檢驗保存。這些應用需要經過驗證的演算法、透明的警報、網路安全措施、高品質的訓練資料以及明確的臨床課責。人工智慧應作為臨床醫生判斷的補充,而非替代。

北美、拉丁美洲、歐洲、中東和非洲以及亞太地區的優先事項各不相同。

在北美,重點通常放在先進的監測、互通性、法規遵循和醫院標準化項目。在歐洲,安全性、醫療設備相容性、永續性以及與互聯醫療保健系統的整合備受重視。在亞太地區,快速發展的三級醫療保健系統,加上新生兒和重症監護基礎設施的顯著差異,催生了對高度適應性系統和培訓支援的需求。在拉丁美洲,經濟性、服務可及性和在異質性醫院網路中可靠的供應往往是優先考慮的因素。中東的醫療保健提供者通常專注於專業醫療保健系統、集中採購和人力資源能力,而非洲市場則特別重視系統的穩健性、技術支援、與氧氣系統的兼容性以及適用於資源條件波動環境的解決方案。

東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約在執行情況方面有明顯差異。

在東協市場,由於醫院容量、監管成熟度和呼吸專科醫生資源的可近性存在顯著差異,模組化實施和現場培訓至關重要。金磚國家成員國的醫療體系規模各異,既有大規模三級醫療體系,也有強烈的本土化生產需求,大都會圈醫療資源取得有差距。歐盟的實施則受通用監管原則以及國家採購和報銷機制的影響。七國集團(G7)國家的醫療體系往往強調實證醫學、互通性、網路安全和全生命週期支持。海灣合作理事會(GCC)成員國的醫療機構通常投資於先進的醫院基礎設施和集中式臨床服務,而北約成員國則可能更加重視供應彈性、標準化、便攜性和重症監護服務的連續性。

各國具體優先事項包括先進的臨床照護、醫療保健服務和韌性。

澳洲和加拿大優先考慮地域適應性強的服務模式以及專科醫院之間的合作。巴西、墨西哥、印度和俄羅斯各地區的醫療服務可近性水準不一,這可能需要成本控制、本地支援和可靠的耗材。中國和韓國在不斷提升先進醫療能力的同時,也注重國內技術生態系統和數位整合。日本優先考慮精準性、可靠性以及老齡化人口的醫療保健需求。法國、德國、義大利和西班牙在結構化的歐洲法規和醫院環境下,兼顧採購效率和臨床證據。英國強調統一的醫療保健服務、互通性和營運價值。美國則高度重視臨床方案、醫療設備效能、合規性和複雜重症監護工作流程的整合。

產業領導者應在整個生命週期中優先考慮安全性、互通性和執行力。

領導者在設計醫療設備時,應圍繞精準給藥、可靠的警報系統、簡化的臨床操作流程以及與人工呼吸器和監護平台的兼容性。此外,設備性能應在新生兒、兒童、成人、轉運以及資源可變等不同使用情境下進行驗證,而非僅針對單一醫療環境進行最佳化。投資於網路安全、遠距離診斷、預防性保養、耗材的持續供應以及基於能力的培訓,可以降低營運風險。區域策略應反映當地的基礎設施和服務能力,證據產生應檢驗病患安全結果、工作流程影響以及整個生命週期的效能,同時避免高估臨床效益。

調查方法:對臨床、技術、監管和區域證據進行結構化審查。

本執行摘要是基於吸入式一氧化氮輸送裝置類別及其所需地理分組的結構化解讀。評估系統地整合了臨床應用、裝置功能、安全控制、數位化整合、基礎設施、採購和法規等各個方面可公開檢驗的考量。區域、群體和國家的具體觀察結果以定性比較的形式呈現,且未對市場規模估算、預測、佔有率或規模做出任何假設。結論應根據目前的臨床指南、適用法規、醫院規程和產品特定的技術文件檢驗。

可靠的管理和符合實際情況的引入對於取得進展至關重要。

吸入式一氧化氮輸送裝置正日益融入重症監護工作流程、呼吸監測、數據系統和醫院安全計畫。為最大限度地發揮其應用效果,可靠的給藥方式、透明的監測、訓練有素的使用者、強大的支持以及基於實證醫學的臨床方案整合至關重要。製造商、醫療服務提供者和政策制定者必須將技術開發與病患安全、公平取得、互通性和長期營運永續性結合。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章 一氧化氮吸入裝置市場:依產品類型分類

  • 連續流裝置
    • 攜帶式
    • 桌上型裝置
  • 脈衝式給藥裝置

第8章 一氧化氮吸入裝置市場:以購買方式分類

  • 購買
  • 租賃
  • 服務合約

第9章 一氧化氮吸入裝置市場:依年齡層別分類

  • 成人
  • 新生
  • 兒童

第10章 一氧化氮吸入裝置市場:依應用分類

  • 肺動脈高壓
    • 原發性肺動脈高壓
    • 續發性肺動脈高壓
  • 呼吸窘迫症候群
    • 成人呼吸窘迫症候群
    • 新生兒呼吸窘迫症候群

第11章 一氧化氮吸入裝置市場:依最終用戶分類

  • 門診部
  • 居家照護環境
  • 醫院
    • 公立醫院
    • 私立醫院

第12章 一氧化氮吸入裝置市場:按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 一氧化氮吸入裝置市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 一氧化氮吸入裝置市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • Air Liquide SA
  • Air Products and Chemicals, Inc.
  • Bellerophon Therapeutics, Inc.
  • Beyond Air, Inc.
  • Chiesi Farmaceutici SpA
  • Circassia Pharmaceuticals plc
  • Draegerwerk AG & Co. KGaA
  • EKU Elektronik
  • General Electric Company
  • Getinge AB
  • International Biomedical
  • Koninklijke Philips NV
  • Linde plc
  • Mallinckrodt Pharmaceuticals Ireland UC
  • Merck KGaA
  • Ninox Medical Ltd.
  • NU-MED Plus
  • Praxair
  • SLE Ltd.
  • SOL SpA
  • Vero Biotech GmbH
  • VNG Medical Innovation System Pvt Ltd

第17章 主要專家

Product Code: MRR-D15065C6038B

The Inhaled Nitric Oxide Delivery Device Market is projected to grow by USD 398.22 million at a CAGR of 6.04% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 264.11 million
Estimated Year [2026] USD 281.53 million
Forecast Year [2032] USD 398.22 million
CAGR (%) 6.04%

Inhaled Nitric Oxide Delivery Devices: Executive Overview

Inhaled nitric oxide delivery devices support controlled administration of nitric oxide in clinical settings, particularly where selective pulmonary vasodilation and oxygenation management are required. Their use is closely linked to neonatal, pediatric, cardiac, pulmonary, and critical-care pathways. Device value depends on accurate dosing, reliable gas blending, continuous monitoring, alarm performance, and safe integration with ventilators and other respiratory equipment.

Clinical Integration and Safety Are Reshaping Device Requirements

The landscape is shifting from standalone gas-delivery equipment toward integrated systems that combine precision dosing, respiratory-circuit compatibility, monitoring, documentation, and workflow support. Hospitals increasingly prioritize uninterrupted operation, straightforward setup, maintenance efficiency, and safeguards against excessive exposure or inadequate delivery. Regulatory scrutiny, infection-prevention expectations, clinician training, and the need for reliable performance during patient transfers are also influencing procurement and implementation decisions.

Artificial Intelligence Strengthens Monitoring, Workflow, and Predictive Support

Artificial intelligence can improve inhaled nitric oxide delivery by identifying deviations in dose, flow, concentration, or circuit behavior and by supporting early detection of maintenance needs. Machine-learning tools may also help correlate device readings with respiratory and hemodynamic data, reducing manual review and strengthening documentation. These applications require validated algorithms, transparent alerts, cybersecurity controls, high-quality training data, and clear clinical accountability; AI should complement rather than replace clinician judgment.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America generally emphasizes advanced monitoring, interoperability, regulatory compliance, and hospital-standardization programs. Europe places strong importance on safety, device conformity, sustainability, and integration with coordinated health systems. Asia-Pacific combines rapidly developing tertiary-care capacity with substantial variation in neonatal and critical-care infrastructure, creating demand for adaptable systems and training support. Latin America often prioritizes affordability, service availability, and dependable supply across uneven hospital networks. Middle Eastern providers commonly focus on specialized-care capacity, centralized procurement, and workforce capability, while African markets place particular emphasis on ruggedness, technical support, oxygen-system compatibility, and solutions suited to resource-variable environments.

ASEAN, BRICS, European Union, G7, GCC, and NATO Show Distinct Adoption Contexts

ASEAN markets differ significantly in hospital capability, regulatory maturity, and access to respiratory specialists, making modular deployment and local training important. BRICS members reflect a mix of large tertiary-care systems, domestic manufacturing ambitions, and uneven access between metropolitan and regional facilities. European Union adoption is shaped by shared regulatory principles alongside national purchasing and reimbursement structures. G7 systems tend to emphasize evidence, interoperability, cybersecurity, and lifecycle support. GCC providers often invest in advanced hospital infrastructure and centralized clinical services, while NATO countries may place additional weight on supply resilience, standardization, transportability, and continuity of critical-care operations.

Country-Level Priorities Span Clinical Sophistication, Access, and Resilience

Australia and Canada emphasize geographically resilient service models and integration across specialized hospitals. Brazil, Mexico, India, and Russia face varied regional access and may prioritize cost control, local support, and dependable consumables. China and South Korea combine expanding advanced-care capabilities with interest in domestic technology ecosystems and digital integration. Japan emphasizes precision, reliability, and aging-care needs. France, Germany, Italy, and Spain operate within structured European regulatory and hospital environments while balancing procurement efficiency and clinical evidence. The United Kingdom focuses on centralized health-service requirements, interoperability, and operational value. The United States places strong emphasis on clinical protocols, device performance, compliance, and integration across complex critical-care workflows.

Industry Leaders Should Prioritize Safety, Interoperability, and Lifecycle Execution

Leaders should design devices around accurate delivery, robust alarms, simple clinician workflows, and compatibility with ventilators and monitoring platforms. They should validate performance across neonatal, pediatric, adult, transport, and resource-variable use cases rather than optimizing for a single care environment. Investment in cybersecurity, remote diagnostics, preventive maintenance, consumable continuity, and competency-based training can reduce operational risk. Regional strategies should reflect local infrastructure and service capacity, while evidence generation should document patient-safety outcomes, workflow effects, and total lifecycle performance without overstating clinical benefit.

Methodology: Structured Review of Clinical, Technical, Regulatory, and Regional Evidence

This executive summary is based on a structured interpretation of the defined inhaled nitric oxide delivery device category and the required geographic groupings. The assessment organizes publicly verifiable considerations across clinical applications, device functionality, safety controls, digital integration, infrastructure, procurement, and regulatory context. Regional, group, and country observations are presented as qualitative comparisons; no market estimates, forecasts, shares, or sizing assumptions are used. Conclusions should be validated against current clinical guidance, applicable regulations, hospital protocols, and product-specific technical documentation.

Reliable Delivery and Context-Aware Implementation Will Define Progress

Inhaled nitric oxide delivery devices are becoming more closely connected to critical-care workflows, respiratory monitoring, data systems, and hospital safety programs. The strongest implementation outcomes will depend on dependable dosing, transparent monitoring, trained users, resilient support, and evidence-based integration into clinical protocols. Manufacturers, providers, and policymakers should align technology development with patient safety, equitable access, interoperability, and long-term operational sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Inhaled Nitric Oxide Delivery Device Market, by Product Type

  • 7.1. Introduction
  • 7.2. Continuous Flow Devices
    • 7.2.1. Portable Devices
    • 7.2.2. Tabletop Devices
  • 7.3. Pulsed Delivery Devices

8. Inhaled Nitric Oxide Delivery Device Market, by Mode Of Purchase

  • 8.1. Introduction
  • 8.2. Purchase
  • 8.3. Rental
  • 8.4. Service Agreements

9. Inhaled Nitric Oxide Delivery Device Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Neonatal
  • 9.4. Pediatric

10. Inhaled Nitric Oxide Delivery Device Market, by Application

  • 10.1. Introduction
  • 10.2. Pulmonary Hypertension
    • 10.2.1. Primary Pulmonary Hypertension
    • 10.2.2. Secondary Pulmonary Hypertension
  • 10.3. Respiratory Distress Syndrome
    • 10.3.1. Adult Distress Syndrome
    • 10.3.2. Neonatal Distress Syndrome

11. Inhaled Nitric Oxide Delivery Device Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care Centers
  • 11.3. Homecare Settings
  • 11.4. Hospitals
    • 11.4.1. Government Hospitals
    • 11.4.2. Private Hospitals

12. Inhaled Nitric Oxide Delivery Device Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Inhaled Nitric Oxide Delivery Device Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Inhaled Nitric Oxide Delivery Device Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Air Liquide S.A.
  • 16.2. Air Products and Chemicals, Inc.
  • 16.3. Bellerophon Therapeutics, Inc.
  • 16.4. Beyond Air, Inc.
  • 16.5. Chiesi Farmaceutici S.p.A.
  • 16.6. Circassia Pharmaceuticals plc
  • 16.7. Draegerwerk AG & Co. KGaA
  • 16.8. EKU Elektronik
  • 16.9. General Electric Company
  • 16.10. Getinge AB
  • 16.11. International Biomedical
  • 16.12. Koninklijke Philips N.V.
  • 16.13. Linde plc
  • 16.14. Mallinckrodt Pharmaceuticals Ireland UC
  • 16.15. Merck KGaA
  • 16.16. Ninox Medical Ltd.
  • 16.17. NU-MED Plus
  • 16.18. Praxair
  • 16.19. SLE Ltd.
  • 16.20. SOL SpA
  • 16.21. Vero Biotech GmbH
  • 16.22. VNG Medical Innovation System Pvt Ltd

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Inhaled Nitric Oxide Delivery Device Market, Years Considered for the Study
  • FIGURE 2. Global Inhaled Nitric Oxide Delivery Device Market, Research Design
  • FIGURE 3. Global Inhaled Nitric Oxide Delivery Device Market, Research Framework
  • FIGURE 4. Global Inhaled Nitric Oxide Delivery Device Market, Data Triangulation
  • FIGURE 5. Global Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2025 vs 2032 (%)
  • FIGURE 9. Global Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2025 vs 2032 (%)
  • FIGURE 11. Global Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Inhaled Nitric Oxide Delivery Device Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Inhaled Nitric Oxide Delivery Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Inhaled Nitric Oxide Delivery Device Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Inhaled Nitric Oxide Delivery Device Market Segmentation & Coverage
  • TABLE 2. Global Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Continuous Flow Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Continuous Flow Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Continuous Flow Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Portable Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Portable Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Portable Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Tabletop Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Tabletop Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Tabletop Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Pulsed Delivery Devices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Pulsed Delivery Devices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Pulsed Delivery Devices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 17. Global Purchase Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Purchase Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Purchase Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Rental Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Rental Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Rental Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Service Agreements Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Service Agreements Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Service Agreements Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 27. Global Adult Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Adult Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Adult Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 37. Global Pulmonary Hypertension Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Pulmonary Hypertension Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Pulmonary Hypertension Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Primary Pulmonary Hypertension Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Primary Pulmonary Hypertension Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Primary Pulmonary Hypertension Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Secondary Pulmonary Hypertension Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Secondary Pulmonary Hypertension Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Secondary Pulmonary Hypertension Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Respiratory Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Respiratory Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Respiratory Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Adult Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Adult Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Adult Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Neonatal Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Neonatal Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Neonatal Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 56. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Government Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Government Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Government Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 74. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 75. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 76. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 77. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 78. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 79. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 80. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 81. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 82. North America Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. North America Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 84. North America Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 85. North America Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 86. North America Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 87. North America Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 88. North America Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 89. North America Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 90. North America Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 91. North America Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 92. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 94. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 95. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 96. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 97. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 98. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 99. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 100. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 101. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 102. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 104. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 105. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 106. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 107. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 108. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 109. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 110. Europe Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 111. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 112. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 114. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 115. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 116. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 117. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 118. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 119. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 120. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 121. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 122. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 124. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 125. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 126. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 127. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 128. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 129. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 130. Africa Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 131. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 132. Global Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 133. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 134. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 135. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 136. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 137. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 138. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 139. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 140. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 141. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 142. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 143. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 144. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 145. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 146. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 147. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 148. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 149. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 150. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 151. GCC Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 152. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 153. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 154. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 155. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 156. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 157. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 158. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 159. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 160. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 161. European Union Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 162. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 163. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 165. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 166. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 167. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 168. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 169. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 170. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 171. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 173. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 174. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 175. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 176. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 177. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 178. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 179. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 180. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 181. G7 Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 182. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 183. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 184. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 185. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 186. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 187. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 188. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 189. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 190. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 191. NATO Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 192. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 193. Global Inhaled Nitric Oxide Delivery Device Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 194. United States Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 195. United States Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 196. United States Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 197. United States Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 198. United States Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 199. United States Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. United States Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 201. United States Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 202. United States Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 203. United States Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 204. Canada Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 205. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 206. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 207. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 208. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 209. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 210. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 211. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 212. Canada Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 213. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 214. Mexico Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 215. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 216. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 217. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 218. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 219. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 220. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 221. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 222. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 223. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 224. Brazil Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 225. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 226. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 227. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 228. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 229. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 230. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 231. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 232. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 234. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 235. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 236. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 237. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 238. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 239. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 240. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 241. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 242. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 243. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 244. Germany Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 245. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 246. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 247. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 248. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 249. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 250. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 251. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 252. Germany Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 253. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 254. France Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 255. France Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 256. France Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 257. France Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 258. France Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 259. France Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 260. France Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 261. France Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 262. France Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 263. France Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 264. Russia Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 265. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 266. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 267. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 268. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 269. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 270. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 271. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 272. Russia Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 273. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 274. Italy Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 275. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 276. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 277. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 278. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 279. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 280. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 281. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 282. Italy Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 283. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 284. Spain Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 285. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 286. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 287. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 288. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 289. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 290. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 291. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 292. Spain Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 293. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 294. China Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 295. China Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 296. China Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 297. China Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 298. China Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 299. China Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 300. China Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
  • TABLE 301. China Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
  • TABLE 302. China Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 303. China Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 304. India Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
  • TABLE 305. India Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 306. India Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
  • TABLE 307. India Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
  • TABLE 308. India Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
  • TABLE 309. India Inhaled Nitric Oxide Delivery Device Market Size, by Application